Seres Therapeutics Inc

XNAS:MCRB 4:00:00 PM EDT

8.81

-0.46 (-4.96%)

6:28:25 PM EDT: $8.98 +0.17 (+1.93%)

Seres Therapeutics Inc Stock, XNAS:MCRB

101 Cambridge Park Drive, 4th floor, Cambridge, Massachusetts 02140

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.